High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis

Digestive Diseases and Sciences

Volumn 50, Issue 6, 2005, Pages 1141-1145

  Bolukbas, Fusun F ^a,c   Bolukbas, Cengiz ^a   Zeyrek, Fadile ^a   Aslan, Mehmet ^a   Bahcecioglu, Halil I ^b   Ozardali, Ilyas ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c Firat University ^*  (Turkey)

Author keywords

Antibody IgA; Chlamydia pneumoniae; Male; Nonalcoholic steatohepatitis; Serology

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; POPULATION RESEARCH; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; STATISTICAL SIGNIFICANCE;

ADULT; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FATTY LIVER; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS;

EID: 20844444160     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2721-7     Document Type: Article

References (31)

1. Alba LM, Lindor K: Review article: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 17:977-986, 2003
2. McCullough AJ: Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 34:255-262, 2002
3. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with hitherto unnamed disease. Mayo Clin Proc 55:434-438, 1980
4. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW: The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74-80, 1990
5. Day CP, James OFW: Steatohepatitis: A tale of two "hits"? Gastroenterology 114:842-845, 1998
6. Pessayre D, Berson A, Fromenty B, Mansouri A: Mitochondria in steatohepatitis. Semin in Liver Dis 21:57-69, 2001
7. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG: The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206-211, 2001
8. Cook PJ, Honeybourne D: Chlamydia pneumoniae. J Antimicrob Chemother 34:859-873, 1994
9. Bahrmand AR, Bahadori M, Hossaini A, Velayati AA, Aghabozorgy S, Shakoor A, Bakayev VV: Chlamydia pneumoniae DNA is more frequent in advanced than in mild atherosclerosis lesions. Scand J Infect Dis 36:119-123, 2004
10. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P: Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 17:2910-2913, 1997
11. Anand V, Gupta S: Antibiotic therapy in coronary heart disease - where do we currently stand? Cardiovasc Drugs Ther 15:209-210, 2001
12. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 29:983-986, 1988
13. Ponsioen CY, Defoer J, Ten Kate FJ, Weverling GJ, Tytgat GN, Pannekoek Y, Wertheim-Dillen PM: A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur J Gastroenterol Hepatol 14:641-648, 2002
14. Schachter J: Pathogenesis of chlamydial infections. Pathol Immunopathol Res 8:206-220, 1989
15. Saikku P: Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 138: S500-S503, 1999
16. Tomasi TB, Grey HM: Structure and function of immunoglobulin A. Prog Allergy 16:81-213, 1972
17. Falck G, Gnarpe J, Hansson LO, Svardsudd K, Gnarpe H: Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest 122:1587-1593, 2002
18. Gore RM: Diffuse liver disease. In Textbook of Gastrointestinal Radiology. RM Gore, MS Levine, I Laufer (eds). Philadelphia, Saunders, 1994, pp 1968-2017
19. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474, 1999
20. Ikai E, Honda R, Yamada Y: Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens 8:95-100, 1999
21. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850, 2001
22. Leinonen M, Saikku P: Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Am Heart J 138:504-506, 1999
23. Muller J, Moller DS, Kjaer M, Nyvad O, Larsen NA, Pedersen EB: Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis 35:704-712, 2003
24. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P: Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. BMJ 314:1456-1457, 1997
25. Bouwman JJ, Visseren FL, Bouter PK, Diepersloot RJ: Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae. J Lab Clin Med 144:8-26, 2004
26. Higuchi M, Aggarwal BB, Yeh ET: Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 99:1751-1758, 1997
27. Inayat-Hussain SH, Couet C, Cohen GM, Cain K: Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes. Hepatology 25:1516-1526, 1997
28. Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, Schuppan D, Rotella CM, Surrenti C: Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology 105:245-253, 1993
29. Lyznicki JM, Young DC, Riggs JA, Davis RM: Council on Scientific Affairs, American Medical Association. Obesity: assessment and management in primary care. Am Fam Phys 63:2185-2196, 2001
30. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T: Liver fibrosis in overweight patients. Gastroenterology 118:1117-1123, 2000
31. Koh WP, Taylor MB, Hughes K, Chew SK, Fong CW, Phoon MC, Kang KL, Chow VT: Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore. Int J Epidemiol 1:1001-1007, 2002